Ads
related to: Vertex and Earnings Per Share- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- The Top IPO Stock Plays
Could IPOs be the Key to Success?
Investing in IPOs is on the Rise
- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Chipmaker Set to Soar Now
Search results
FY2026 Earnings Estimate for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Issued By Zacks...
ETF DAILY NEWS· 2 weeks agoZacks Research analyst R. Department now forecasts that the pharmaceutical company will post earnings per share...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to Post Q1 2025 Earnings of $3.52 Per Share, Zacks...
ETF DAILY NEWS· 1 week agoVertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) – Investment analysts at Zacks Research upped their Q1 2025 earnings per
This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy?
Motley Fool via Yahoo Finance· 1 week agoLast year, Vertex Pharmaceuticals' sales increased by 11% year over year to $9.87 billion, while its...
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks via Yahoo Finance· 1 week agoThis has was narrower than the Medical sector's loss of 3.76% and lagged the S&P 500's gain of 1.78%...
Merck, Vertex could beat expectations despite more subdued 1Q biopharma earnings anticipated: BofA...
Investing.com· 6 days agoMerck, Vertex could beat expectations despite more subdued 1Q biopharma earnings anticipated: BofA
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to “Strong-Buy” at StockNews.com
ETF DAILY NEWS· 5 days agoRoyal Bank of Canada lifted their price objective on Vertex Pharmaceuticals from $397.00 to $420.00 and gave the stock a sector perform rating in a research report on Tuesday ...
Nisa Investment Advisors LLC Sells 222 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 1 week agoNisa Investment Advisors LLC lessened its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.3% in the 4th quarter, according to its most ...
Jeffrey Westphal Sells 791,133 Shares of Vertex, Inc. (NASDAQ:VERX) Stock
ETF DAILY NEWS· 1 week agoVertex, Inc. (NASDAQ:VERX – Get Free Report) major shareholder Jeffrey Westphal sold 791,133 shares of the stock in a transaction on Friday, April 5th. Following the completion ...
bluebird (BLUE) Underperforms Industry YTD Amid Challenges
Zacks via Yahoo Finance· 2 days agoYou can see the complete list of today’s Zacks #1 Rank stocks here. In the past 60 days, estimates...
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper...
MarketWatch via Yahoo Finance· 1 week agoCytokinetics, Inc. Ticker 2023 sales 2024 estimated sales 2025 estimated sales Two-year estimated...